A. Tran, H. Ly
The management of SJS/TEN remains a controversial area. In our study we aim to evaluate the views of SJS/ TEN management amongst Dermatologists in Australia.
The survey we present covers questions about preferences for hospitalization, skin care, supportive management and adjunct systemic therapies, including the use of oral ster- oids, intravenous immunoglobulin, cyclosporine, c-GSF and TNF-a blockers. Questions are scored from 1 to 5 (strongly agree to strongly disagree). The survey has been sent to fel- lows of the ACD and we have collated their responses.
The Annual Scientific Meeting in Adelaide in 2020 will host Dr Neil Shear from Canada, who is an expert in this field. We hope to present the results of the survey at the meeting, thereby facilitating discussion on management of this condition.
There were no categories that were appropriate for SJS/ TEN so I selected the Free Paper option. However, we were hoping to present our findings at the symposium on TEN. Thank you for your consideration.